References
- SumiyoshiTSuzukiKSakamotoHAtypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancyNeuropsychopharmacology199512157647766287
- VanelleJMOliéJPLévy-SoussanPNew antipsychotics in schizophrenia: the French experienceActa Psychiatr Scand Suppl199438059637914051
- HigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]The Cochrane Collaboration2011 Available from www.cochrane-handbook.orgAccessed November 12, 2014
- OkaTHamamuraTLeeYAtypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brainLife Sci200476222523715519367
- 031-95-003 (study name)Clinical evaluation of aripiprazole in schizophrenic patients: A comparative double-blind study with mosapramine Available from: http://www.info.pmda.go.jp/shinyaku/P200600001/18007800_21800AMZ10011_G100_1.pdf#search=’03195003’Accessed November 12, 2014 Japanese
- KudoYNomuraJIkawaGNakajimaTSaitoMSakaiTClinical evaluation of quetiapine fumarate for the treatment of schizophrenia: a double-blind controlled study using mosapramine hydrochloride as a controlRinsyo Iyaku20001618071842 Japanese
- KudoYNakajimaTSaitoMClinical evaluation of a serotonin-2 and dopamine-2 receptor antagonist (SDA), perospirone HCI on schizophrenia -A comparative double-blind study with mosapramine HCIClinical Evaluations199724207248 Japanese
- MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementBMJ2009339b253519622551
- KaySROplerLALindenmayerJPThe Positive and Negative Syndrome Scale (PANSS): rationale and standardisationBr J Psychiatry Suppl1989759672619982
- InadaTYagiGMiuraSExtrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidolSchizophr Res2002572–322723812223254
- InadaTYagiGCurrent topics in neuroleptic-induced extrapyramidal symptoms in JapanKeio J Med199645295998683905
- DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
- HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
- KudoYA double-blind comparison of pimozide with carpipramine in schizophrenic patientsActa Psychiatr Belg19727266856974606115
- KondoHImaiHTakahashiSA double-blind comparison of penfluridol with carpipramine in schizophrenic patientsJapanese Journal of Clinical Psychiatry197541113731386 Japanese
- TanimukaiHKanekoJA double-blind comparison of oxypertine with carpipramine in schizophrenic patientsSeishin Igaku19701215564 Japanese
- ItoNNaitoHSatoSA double-blind comparison of PJ-929 with carpipramine in chronic schizophreniaClinical Evaluations197423409428 Japanese
- KatoNTakahashiRYagiGKazamatsuriHMoriAMurasakiMA double-blind comparison of new iminodibenzyl compound Y-516 with clocapramine in the phamacotherapy of schizophreniaClinical Evaluation198917177196 Japanese
- KudoYNakajimaTNishimuraKClinical evaluation of risperidone in schizophrenia: A double-blind comparative study of risperidone with clocapramineJapanese Journal of Clinical Psychiatry199423233249 Japanese [with English abstract]
- YamagamiSKiriikeNKawaguchiKA single-blind study of clocapramine and sulpiride in hospitalized chronic schizophrenic patientsDrugs Exp Clin Res19881411707713 Japanese3246215
- KudoYIchimaruSKawakitaYA double blind comparison of bromperidol and clocapramine on schizophreniaJapanese Journal of Clinical Psychiatry1984131012831301 Japanese
- MukasaHMatsunagaKNakamuraJA double blind comparison of bromperidol and clocapramine on schizophreniaJapanese Journal of Clinical and Experimental Medicine19846111279289 Japanese
- KuriharaMItoNKatoNKawakitaYKudoYMoriAClinical evaluation of clocapramine (clofekton) in schizophrenia: a double-blind comparison of clocapramine, haloperidol and perphenazineJapanese Journal of Clinical Psychiatry1983124519538 Japanese
- KudoYNishimuraKSaitoMOtsukiSInanagaKNakajimaTA double-blind comparison of Y-516 with haloperidol in schizophrenic patientsJournal of Clinical and Experimental Medicine1990152529542 Japanese
- LeuchtSCiprianiASpineliLComparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysisLancet2013382989695196223810019
- Rummel-KlugeCKomossaKSchwarzSSecond-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisonsSchizophr Bull201238116717720513652